Application forms for NSW authorisation to prescribe or supply Schedule 8 (S8) drugs are listed below. Note that forms may be updated from time to time. ​​

Please note that a number of authority application forms have recently been updated. These new forms are quicker to complete and require less information and supporting documentation from prescribers.  Please note that there are declarations at the beginning and the end of the forms. Applicants must ensure they complete and submit both declarations. Old application forms will no longer be accepted from 1 February 2023.

If you have any questions or would like to provide feedback on the new application forms, please email:
MOH-S8Auth@health.nsw.gov.au

Information on legal requirements for an authority to prescribe drugs of addiction in NSW are also available.

On this page

Pain management

To apply for authorisation to prescribe or supply a Schedule 8 opioid (e.g. oxycodone, morphine or fentanyl) or another S8 drug for the management of pain in a patient, complete an Application for authority to prescribe or supply a Schedule 8 drug - pain management (Updated form).

Attention Deficit Hyperactivity Disorder (ADHD) in a child, adolescent, or adult  

The application for the treatment of ADHD in an adult has now merged into one form – a combined application form for ADHD for children, adolescents, adults, and high dose.

To apply for authorisation to prescribe or supply a psychostimulant (dexamfetamine, lisdexafetamine or methlyphenidate) for the management of ADHD in a child, adolescent, or adult patient, complete an Application for authority to prescribe or supply a Schedule 8 drug - Psychostimulant for Attention Deficit Hyperactivity Disorder (ADHD) (Updated form).

The same application form may be used to prescribe a high dose of psychostimulant for the management of ADHD in a child, adolescent, or adult.

Psychostimulant for treatment of an indication other than ADHD

To apply for authorisation to prescribe a psychostimulant for the management of a diagnosis other than ADHD in a child, adolescent, or adult patient, complete an Application for authority to prescribe or supply a Schedule 8 psychostimulant, other than for ADHD, for children and adults (Updated form).

Alprazolam and flunitrazepam

To apply for authorisation to prescribe or supply alprazolam or flunitrazepam, complete an Application for authority to prescribe a Schedule 8 drug - alprazolam or flunitrazepam (Updated form).

NSW Opioid Treatment Program (OTP)

Applications for authority to prescribe or supply methadone or buprenorphine under the NSW OTP are to be made using one form (rather than a separate form for each drug). To apply for authorisation complete an Application for authority to prescribe methadone or buprenorphine under the NSW Opioid Treatment Program.

Interstate prescribers who wish to temporarily transfer a patient to the NSW OTP are required to complete an Application for temporary interstate transfer to NSW Opioid Treatment Program.

To exit a person from the NSW OTP complete an Exit from methadone or buprenorphine treatment under the NSW Opioid Treatment Program.

Certain restricted substances

To apply for authorisation to prescribe the certain restricted substances (acitretin, clomiphene, cyclofenil, dinoprost, dinoprostone, etretinate, follitropin beta, hydroxychloroquine, isotretinoin for oral use, ivermectin, luteinising hormone, tretinoin for oral use, urofollitrophin (human follicle stimulating hormone)) complete an Application for authority to prescribe certain restricted substances. (Updated form)

Unregistered or (pharmacy) extemporaneously-compounded S8 product

To apply for authorisation to prescribe or supply an extemporaneously-compounded Schedule 8 product or an unregistered S8 medicine (other than a cannabis medicine) complete an Application for authority to prescribe an unregistered or (pharmacy) extemporaneously - compounded Schedule 8 product for human therapeutic use. (Updated form)

Cannabis medicines

To apply for authorisation to prescribe or supply a cannabis-based product for therapeutic use complete an Application for authority to prescribe or supply a Schedule 8 cannabis medicine for human therapeutic use. (updated form)

Esketamine or ketamine for treatment resistant depression

To apply for authorisation to prescribe esketamine, complete an Application for authority to prescribe or supply esketamine or ketamine for treatment resistant depression. (Updated form)

Human research (Clinical trial)

To apply for authorisation to prescribe and supply a substance for the purpose of human research complete an Application for authority to prescribe and supply a substance for the purpose of human research.


Current as at: Thursday 22 December 2022
Contact page owner: Pharmaceutical Services